Supplementary material for "Crinecerfont lowers elevated hormone markers in adults with 21-hydroxylase deficiency congenital adrenal hyperplasia"

Published: 6 July 2021| Version 1 | DOI: 10.17632/bj6nn9343p.1
Contributor:
Eric Jen

Description

Supplementary material for crinecerfont Phase 2 study in CAH.

Files

Categories

Congenital Disorder, Clinical Endocrinology, Clinical Trial Results

Licence